Skip to main content

Table 1 Baseline characteristics of study subjects by tertiles of change in dietary phylloquinone intake (μg/day)

From: Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk

Characteristics

All subjects (n=510)

P

Tertile 1

Tertile 2

Tertile 3

(−718.2 to −69.9)

(−26.8 to 69.4)

(70.5 to 767.5)

Clinical characteristics

    

Men/women, n

80/92

68/107

78/85

0.194

Age, years

66.8 ± 6.1

68.1 ± 6.2

66.6 ± 5.7

0.030

BMI, kg/m2

29.39 ± 3.17

29.21 ± 3.18

29.17 ± 3.05

0.608

Waist circumference, cm

100.6 ± 8.6

100.5 ± 9.2

100.9 ± 8.9

0.940

Current smoker, n (%)

26 (15.1)

29 (16.6)

16 (9.8)

0.561

Type 2 diabetes, n (%),

95 (55.2)

100 (57.1)

85 (52.1)

0.650

Overweight/Obesity, n (%)

159 (92.4)

162 (92.6)

149 (91.4)

0.911

Hypertension, n (%)

156 (90.7)

164 (93.7)

148 (90.8)

0.121

Dyslipydemia, n (%)

103 (61.7)

116 (68.6)

92 (57.9)

0.511

Intervention group MD+VOO/MD+nuts/CD, n

44/54/74

64/57/54

76/45/42

0.001

Leisure-time physical activity, METS-min/day

277.8 ± 261.9

263.0 ± 247.8

294.2 ± 279.4

0.313

Metabolic risk markers

    

C-Peptide (ng/mL)

1.41 (1.34 to 1.49)

1.33 (1.24 to 1.44)

1.34 (1.25 to 1.42)

0.374

Ghrelin (pg/mL)

12.88 (11.95 to 3.89)

13.38 (12.31 to 14.54)

12.77 (11.75 to 13.87)

0.685

GIP (pg/mL)

92.55 (84.76 to 101.05)

98.40 (89.70 to 107.95)

85.72 (78.25 to 93.91)

0.107

GLP-1 (ng/mL)

1.22 (1.09 to 1.36)

1.31 (1.17 to 1.48)

1.16 (1.03 to 1.30)

0.312

IL-6 (pg/ml)

9.96 (8.80 to 11.27)

10.88 (9.63 to 12.29)

8.99 (7.93 to 10.19)

0.102

Leptin (ng/mL)

2.87 (2.60 to 3.17)

3.20 (2.88 to 3.57)

2.91 (2.63 to 3.22)

0.262

PAI-1 (ng/mL)

3.20 (3.05 to 3.37)

3.28 (3.11 to 3.46)

3.37 (3.21 to 3.54)

0.378

Resistin (ng/mL)

0.98 (0.92 to 1.05)

1.05 (0.98 to 1.12)

1.01 (0.94 to 1.08)

0.413

TNF (pg/mL)

13.36 (11.57 to 15.44)

13.76 (11.89 to 15.93)

11.35 (9.80 to 13.14)

0.145

Visfatin (ng/mL)

4.13 (3.53 to 4.84)

4.54 (3.85 to 5.37)

3.70 (3.13 to 4.37)

0.225

Adiponectin (μg/mL)

48.87 (42.67 to 55.98)

49.51 (42.68 to 57.43)

42.37 (35.45 to 50.64)

0.302

Adipsin (μg/mL)

1.12 (1.01 to 1.24)

1.14 (1.03 to 1.28)

0.91 (0.77 to 1.08)

0.029

  1. Data are given as mean (SD) or number (%) unless otherwise indicated. Metabolic risk markers are expressed as geometric means (IC95%). P values of the difference between tertils of change in dietary phylloquinone intake (ANOVA for the continuous variables and a χ 2 test for categorical variables). MD+VOO Mediterranean diet + Virgin Olive Oil, MD+nuts Mediterranean diet + Nuts, CD Control diet, BMI body mass index, GLP-1 glucagon-like peptide 1, GIP glucose-dependent insulinotropic polypeptide; IL-6 interleukin-6, PAI-1 plasminogen activator inhibitor-1, TNF-α tumor necrosis factor-α.